Your search returned 5 results.

Results
	1.	Genetically engineered T cells as adoptive immunotherapy of cancer. [electronic resource] by Ma, Qiangzhong Gonzalo-Daganzo, Rosa M Junghans, Richard P Producer: 20030527 In: Cancer chemotherapy and biological response modifiers vol. 20 Availability: No items available. Save to lists Add to cart (remove)
	2.	Second-generation anti-carcinoembryonic antigen designer T cells resist activation-induced cell death, proliferate on tumor contact, secrete cytokines, and exhibit superior antitumor activity in vivo: a preclinical evaluation. [electronic resource] by Emtage, Peter C R Lo, Agnes S Y Gomes, Erica M Liu, David L Gonzalo-Daganzo, Rosa M Junghans, Richard P Producer: 20090106 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequencies. [electronic resource] by Giest, Sandra Grace, Sarah Senegaglia, Alexandra C Pasquini, Ricardo Gonzalo-Daganzo, Rosa M Fernández, Manuel N Mackinnon, Stephen Madrigal, J Alejandro Travers, Paul J Producer: 20100511 In: British journal of haematology vol. 148 Availability: No items available. Save to lists Add to cart (remove)
	4.	Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequencies. [electronic resource] by Giest, Sandra Grace, Sarah Senegaglia, Alexandra C Pasquini, Ricardo Gonzalo-Daganzo, Rosa M Fernández, Manuel N Mackinnon, Stephen Madrigal, J Alejandro Travers, Paul J Publication details: British journal of haematology Jan 2010 In: British journal of haematology vol. 148 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial. [electronic resource] by Gómez-Barrena, Enrique Rosset, Philippe Gebhard, Florian Hernigou, Philippe Baldini, Nicola Rouard, Helène Sensebé, Luc Gonzalo-Daganzo, Rosa M Giordano, Rosaria Padilla-Eguiluz, Norma García-Rey, Eduardo Cordero-Ampuero, José Rubio-Suárez, Juan Carlos Stanovici, Julien Ehrnthaller, Christian Huber-Lang, Markus Flouzat-Lachaniette, Charles Henri Chevallier, Nathalie Donati, Davide Maria Ciapetti, Gabriela Fleury, Sandrine Fernandez, Manuel-Nicolás Cabrera, José-Rafael Avendaño-Solá, Cristina Montemurro, Tiziana Panaitescu, Carmen Veronesi, Elena Rojewski, Markus Thomas Lotfi, Ramin Dominici, Massimo Schrezenmeier, Hubert Layrolle, Pierre Producer: 20200515 In: Biomaterials vol. 196 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)